Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted
Links shared publicly online about this topic.
- 461total visits
Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, High Blood Pressure, High Blood Pressure Medication, Liver, Drug, Pulmonology
Most Recently Shared on March 5, 2011 at 7:37 pm By:
Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted: The FDA (Food and Drug .. http://dld.bz/QJDS
Also Shared By:
Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted - QualityPoint Technologies
qualitypointtech.net — “The FDA (Food and Drug Administration) has lifted a boxed warning on the labels of prescription drug Letairis (ambrisentan 5 mg and 10 mg tablets) aimed at patients with worsening pulmonary arterial hypertension to improve exercise ability and slow down worsening symptoms. The Boxed Warning referred to a possible risk of liver injury. Now, those on Letairis no longer have to undergo regular monthly liver function tests, makers Gilead Sciences announced. The FDA says it has lifted the Boxed Warni” View full resource at qualitypointtech.net
Most Recently Shared on March 5, 2011 at 7:35 pm By:
Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted: The FDA (Food and ... http://bit.ly/h8Wo6g
Advertisement
MNT Health News
@mnt_healthnews
Pulmonary Arterial Hypertension Drug Letairis Boxed Warning Regarding Liver Injury Risk Lifted http://mnt.to/3RWn #healthnews
1 year ago...